DBS Biosimilars
Buyer: Tirol Kliniken GmbH
- Published
- 23 February 2026
- Estimated value
- €347,448
- Procedure
- Restricted procedure
- Lots
- 1
- Notice number
- 00125266-2026
- Reference
- ec866238-6951-4ca2-94e3-73428aa7a6b7
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
Belieferung der Auftraggeberin mit Bevacizumab
Award criteria
- Quality — Für das Zuschlagskriterium Qualität werden maximal 20 Punkte vergeben.
- Price — Für das Zuschlagskriterium Preis werden maximal 80 gewichtete Punkte vergeben.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| STADA Arzneimittel Gesellschaft m.b.H. | €347,448 | — |
Official publications
- TED · 00125266-2026 · 23 February 2026
- OJS · 37/2026 · 23 February 2026
Other tenders from Tirol Kliniken GmbH
- Rahmenvereinbarung Abschlussprüfung (2027 - 2033) RA 05/01-021
- DBS Fibrinogen 2027, RA 05/30-031
- Immunhistochemie, VVmB RV DBS (RA 09/84a-005)
- DBS Paracetamol 2027
- BKH Schwaz - Neubau Bildungszentrum - Türsysteme aus Stahl - Vollbautüren
- Abschluss einer Rahmenvereinbarung von vorgefüllten NaCl Einmalspritzen
- LKI 3 FKF G0 BGZ Gender Imaging - Möbeltischlerarbeiten
- LKH - Neubau Haus 2 Aufzugsanlagen
- LKH 2 - Neubau Haus 2 WKDSM
- LKH 2 - Neubau Haus 2 Elektroinstallationen
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €347,448.
- Who is the buyer of this tender?
- The contracting authority is Tirol Kliniken GmbH (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.
Create a free account and receive new public tenders published in the European Union that match your business, every day.